Novo Nordisk Live(@NovoNordiskLive):The global POSEIDON study assembles real‑world evidence from 18,000+ patients across 18 countries. Findings put the global burden of CV inflammation in HF on record.1 Learn more at ESC Congress 2026, Hall A2 Stand T100.

2026.08.13 07:48

The global POSEIDON study assembles real‑world evidence from 18,000+ patients across 18 countries. Findings put the global burden of CV inflammation in HF on record.1 Learn more at ESC Congress 2026, Hall A2 Stand T100.

显示更多

677

转发到社区

热门用户

191.4K 粉丝

1.9M 粉丝

30.6K 粉丝

4.1M 粉丝

180.5K 粉丝

206.9K 粉丝

230.9K 粉丝

547.1K 粉丝

194.2K 粉丝

126.6K 粉丝

100K 粉丝

41.6K 粉丝

348.3K 粉丝

11K 粉丝

23.7K 粉丝